Two to buy
Vestas
(Investors Chronicle) Denmark’s Vestas has installed almost a fifth of the world’s wind-turbine capacity outside China. It is the world’s top supplier of onshore turbines. Government subsidies to the “green” economy have made wind power more popular, but increased competition has squeezed margins. That problem should subside this year, however, and “momentum is building in higher-margin servicing” post-installation. The company has been debt-free since 2013 and has over £1bn of net cash. A valuation of 26 times 2021 earnings is reasonable given the auspicious long-term outlook. 943kr
Pernod Ricard
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Times) France’s Pernod Ricard is the world’s second-biggest drinks group behind Diageo. Activist investor Elliott Advisors had been pressing it to merge with a large rival to improve operating margins, but CEO Alexandre Ricard – whose family hold 14.2% of shares and 20.1% of the voting rights – gave the idea “short shrift”. However, he is following a policy of “bolt-on acquisitions” and improving margins is part of his plan. Despite Covid-19 and a €999m writedown (largely due to Absolut Vodka, which relies on airport sales), it has increased its market share while profits have fallen less than expected. €142
Two to sell
J Sainsbury
(Investors Chronicle) The supermarket group had steadied the ship after the pricey failed merger with Asda, but the pandemic has brought new problems, notably a squeeze on margins amid a shift towards less profitable online sales and large potential losses at its bank. The balance sheet remains “stretched”. The shares are inexpensive, but the growing army of short-sellers is right to sense “a value trap”. 213p
FirstGroup
(The Times) “There is... no case for investing in a UK public transport stock.” This train and bus operator has not paid a dividend since 2013 and is struggling to cope with its debt load. And don’t count on matters improving. The sale of its US operations, first announced in March, will produce little money and Britain’s semi-privatised railway system looks likely to be scrapped. Bus systems need massive investment. Avoid. 50p
...and the rest
The Daily Telegraph
Aviva’s new CEO Amanda Blanc aims to reform the underperforming insurance giant. Its “decent digital capability” and strong balance sheet bode well. Covid-19-related claims may inflate premiums. Buy (274p). Cable-assemblies maker Volex “has put its house in order and profits have responded”. Hold (189p).
Investors Chronicle
Derwent London “was one of the few commercial property groups to increase its dividend in the wake of Covid-19”. A solid balance sheet allows it to shrug off “short-term pain on rent collection”. Buy (310p).
Shares
Inspecs, an Aim-listed eyewear-frame maker, offers an appealing “growth story”. People will be rushing to catch up on eye appointments now that lockdown has lifted and there are still 2.6 billion people worldwide who need their vision corrected. Buy (230p).
-
Dividends: Reliability in uncertain timesDividends have formed over half of the total return of the UK market over the last 20 years. Dividend strategies have been under-appreciated while investors have focused on US mega cap technology. Income strategies may have more appeal in a tougher investment climate
-
Trump’s tariffs: what is he thinking and how should UK respond?Every right-thinking person knows that free trade is a surer route to the wealth of nations than protectionism, says Stuart Watkins. What is Trump thinking?
-
The star small and mid-cap stocks income investors have overlookedOpinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Chemring Group: an explosive investment opportunity in defenceEuropean states are raising their military spending, and Chemring Group looks well placed to profit
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
-
Best of British bargains: cash in on undervalued companies in the UK stock marketOpinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
-
Building firm Keller presents low debt and ample scope for growthGeotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
-
PZ Cussons share price down 75% in last decade – why it's one to watchOpinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharmaOpinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
